The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An explorative phase 2 study of afatinib for advanced cancers carrying an EGFR, a HER2 or a HER3 mutation: A Precision trial of the Belgian Society of Medical Oncology.
 
Lore Decoster
Consulting or Advisory Role - Roche (Inst)
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Nadia Cappoen
No Relationships to Disclose
 
Philippe Georges Aftimos
Honoraria - Amgen; Synthon
Consulting or Advisory Role - Boehringer Ingelheim; Macrogenics
Travel, Accommodations, Expenses - Amgen; MSD
 
Gordana Raicevic
No Relationships to Disclose
 
Christian Diego Rolfo
Consulting or Advisory Role - Mylan
Speakers' Bureau - Boehringer Ingelheim; MSD; Novartis
Research Funding - Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Sylvie Rottey
No Relationships to Disclose
 
Francois P. Duhoux
Consulting or Advisory Role - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche; Teva
 
Joelle Collignon
No Relationships to Disclose
 
Aline Hebrant
No Relationships to Disclose
 
Marc Vandenbulcke
No Relationships to Disclose
 
Jacques De Greve
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Roche Belgium